Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis (Q33901936)

29 July 2017

title

Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis (English)

1 reference

ORCID Public Data File 2021

29 July 2017

0 references

1 reference

author name string

Baggi F

1

1 reference

29 July 2017

Andreetta F

2

1 reference

29 July 2017

Caspani E

3

1 reference

29 July 2017

Milani M

4

1 reference

29 July 2017

Longhi R

5

1 reference

29 July 2017

Mantegazza R

6

1 reference

29 July 2017

Cornelio F

7

1 reference

29 July 2017

Antozzi C

8

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Journal of Clinical Investigation

29 July 2017

published in

1 reference

29 July 2017

volume

104

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

1287-1295

1 reference

Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Factors that determine the severity of experimental myasthenia gravis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Immune responses to dietary antigens: oral tolerance.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Pathogenesis of myasthenia gravis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Late complications of immune deviation therapy in a nonhuman primate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Oral tolerance in myasthenia gravis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Myasthenia gravis: recognition of a human autoantigen at the molecular level.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Immunochemical studies on acetylcholine receptor from Torpedo californica

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=409818

Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors

5 July 2018

1 reference

12 December 2020

Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor

1 reference

12 December 2020

The pathogenic role of acetylcholine receptor alpha chain epitope within alpha 146-162 in the development of experimental autoimmune myasthenia gravis in C57BL6 mice

1 reference

12 December 2020

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis

1 reference

12 December 2020

Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor

1 reference

12 December 2020

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

1 reference

12 December 2020

Cytokines and the pathogenesis of myasthenia gravis

1 reference

12 December 2020

Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis

1 reference

12 December 2020

Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis

1 reference

12 December 2020

Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals

1 reference

12 December 2020

Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma

1 reference

12 December 2020

Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81

1 reference

12 December 2020

IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease

1 reference

12 December 2020

Early-onset myasthenia gravis: a recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a

1 reference

12 December 2020

Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI7121

1 reference

29 July 2017

1 reference

29 July 2017

1 reference